Switzerland: Detection of Pathogens Rapid Identification of Pathogens: Tecan Launches New RNA-Seq Kit
The new Revelo RNA-Seq kit from Tecan offers end-to-end processing of human samples to enable complete viral RNA-Seq library preparation — including library quantification — in a single day.
Männedorf/Switzerland — The Revelo RNA-Seq kit has been developed specifically to address the pathogen detection and characterization challenges currently faced by laboratories around the world, and is suited to NGS library preparation from low input, patient-derived sample types, such as nasal swabs. Revelo RNA-Seq offers a user-friendly solution for cost-effective, same-day library preparation by combining an enhanced version of Tecan’s SPIA (Single Primer Isothermal Amplification) technology with the company’s fluorescence-based Nuquant library quantification. Optimized to provide high sensitivity for degraded or low copy number viral RNA in human samples, it allows rapid, sensitive identification and characterization of pathogens. The new kit has already been tested with a range of patient-derived samples containing pathogens, such as Sars-Cov-2 and other respiratory diseases. The automation-friendly kit has also been implemented on Tecan’s Dreamprep NGS workstation to offer a complete, automated solution for walkaway processing, helping to increase throughput and efficiency in busy labs.